TapewireFind a company

organization · Reporting owner

Radoff Family Foundation

Disclosed activity across 7 companies

Tapewire entity
26841
SEC CIK
0001496916

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BARNWELL INDUSTRIES INCBRN · Entity 7823See Footnote 1March 28, 2026March 31, 2026
FARMER BROTHERS COFARM · Entity 49843See Footnote 1October 05, 2022October 07, 2022
KVH INDUSTRIES INC \DE\KVHI · Entity 6612See Footnote 1May 27, 2026May 30, 2026
Lifevantage CorpLFVN · Entity 6941See Footnote 1August 11, 2023August 15, 2023
REGIONAL HEALTH PROPERTIES, INCRHEP · Entity 8343See Footnote 1April 13, 2026August 04, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BARNWELL INDUSTRIES INC

Report date March 28, 2026 · Filed March 31, 2026

Jointly reported with Radoff Bradley Louis

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, $0.50 par valueSEC Table I · non-derivativeDirect560,091 Reported balance Holding disclosure · report date 2026-03-28 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 560,091

F1: This Form 3 is filed jointly by Bradley L. Radoff and The Radoff Family Foundation ("Radoff Foundation" and collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, $0.50 par value. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Common Stock, $0.50 par valueSEC Table I · non-derivativeIndirectBy The Radoff Family Foundation560,090 Reported balance Holding disclosure · report date 2026-03-28 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 560,090

F1: This Form 3 is filed jointly by Bradley L. Radoff and The Radoff Family Foundation ("Radoff Foundation" and collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, $0.50 par value. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Common WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.65 · Expires 2029-05-27DirectNot disclosed Reported balance Holding disclosure · report date 2026-03-28 · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · Balance Not disclosed

F1: This Form 3 is filed jointly by Bradley L. Radoff and The Radoff Family Foundation ("Radoff Foundation" and collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, $0.50 par value. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Common WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.65 · Expires 2029-05-27IndirectBy The Radoff Family FoundationNot disclosed Reported balance Holding disclosure · report date 2026-03-28 · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · Balance Not disclosed

F1: This Form 3 is filed jointly by Bradley L. Radoff and The Radoff Family Foundation ("Radoff Foundation" and collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, $0.50 par value. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 3 is filed jointly by Bradley L. Radoff and The Radoff Family Foundation ("Radoff Foundation" and collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, $0.50 par value. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

FARMER BROTHERS CO

Report date October 05, 2022 · Filed October 07, 2022

Jointly reported with Radoff Bradley Louis

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy The Radoff Family Foundation125,000 Reported balance After 2022-10-05 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 2 · 2022-10-05 · Purchase · Acquired 50,000 · Balance 125,000

F1: The Reporting Persons may be deemed to be members of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that he or it is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Securities owned directly by the Radoff Foundation. As a director of the Radoff Foundation, Mr. Radoff may be deemed to beneficially own the securities owned directly by the Radoff Foundation.

Common StockSEC Table I · non-derivativeDirect200,000 Reported balance Holding disclosure · report date 2022-10-05 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 200,000

F1: The Reporting Persons may be deemed to be members of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that he or it is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: The Reporting Persons may be deemed to be members of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that he or it is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Securities owned directly by the Radoff Foundation. As a director of the Radoff Foundation, Mr. Radoff may be deemed to beneficially own the securities owned directly by the Radoff Foundation.

KVH INDUSTRIES INC \DE\

Report date May 27, 2026 · Filed May 30, 2026

Jointly reported with Radoff Bradley Louis

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy The Radoff Family Foundation290,000 Last balance in matching sequence After 2026-05-27 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 1 · 2026-05-27 · Sale · Disposed 10,941 · Balance 314,059

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.7600 to $10.9550, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Row 2 · 2026-05-27 · Sale · Disposed 24,059 · Balance 290,000

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F4: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.9600 to $11.9600, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Common StockSEC Table I · non-derivativeDirect2,180,000 Reported balance Holding disclosure · report date 2026-05-27 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 2,180,000

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

F3: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.7600 to $10.9550, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.

F4: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.9600 to $11.9600, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.

Lifevantage Corp

Report date August 11, 2023 · Filed August 15, 2023

Jointly reported with Radoff Bradley Louis

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy The Radoff Family Foundation50,000 Reported balance After 2023-08-11 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2023-08-11 · Purchase · Acquired 20,000 · Balance 50,000

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by the other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Common StockSEC Table I · non-derivativeDirect811,250 Reported balance Holding disclosure · report date 2023-08-11 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 811,250

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by the other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by the other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

REGIONAL HEALTH PROPERTIES, INC

Report date April 13, 2026 · Filed August 04, 2026

Jointly reported with Radoff Bradley Louis

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect220,737 Last balance in matching sequence After 2026-04-22 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rows

Row 1 · 2026-04-13 · Purchase · Acquired 6,300 · Balance 215,226

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Row 2 · 2026-04-14 · Purchase · Acquired 3,511 · Balance 218,737

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Row 3 · 2026-04-22 · Purchase · Acquired 2,000 · Balance 220,737

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Common StockSEC Table I · non-derivativeIndirectBy The Radoff Family Foundation105,900 Last balance in matching sequence After 2026-06-15 transaction · row 9 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
6 source rows

Row 4 · 2026-04-13 · Purchase · Acquired 100 · Balance 108,491

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Row 5 · 2026-04-22 · Purchase · Acquired 500 · Balance 108,991

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Row 6 · 2026-04-27 · Purchase · Acquired 1,000 · Balance 109,991

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Row 7 · 2026-04-29 · Purchase · Acquired 1,009 · Balance 111,000

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Row 8 · 2026-06-05 · Sale · Disposed 5,000 · Balance 106,000

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Row 9 · 2026-06-15 · Sale · Disposed 100 · Balance 105,900

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Series D Preferred StockSEC Table II · derivative / convertible securityDirect170,263 Reported balance After 2026-04-14 transaction · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · 2026-04-14 · Purchase · Acquired 600 · Balance 170,263

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

Series D Preferred StockSEC Table II · derivative / convertible securityDirect171,263 Reported balance After 2026-04-15 transaction · row 11 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 11 · 2026-04-15 · Purchase · Acquired 1,000 · Balance 171,263

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

F3: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Guardion Health Sciences, Inc.

Report date August 26, 2024 · Filed August 28, 2024

Jointly reported with Radoff Bradley Louis

Section 16 reporting ended · disclosed 2024-08-28. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect112,414 Last balance in matching sequence After 2024-08-26 transaction · row 3 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rows

Row 1 · 2024-08-26 · Sale · Disposed 52,686 · Balance 165,214

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.05 to $13.85 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Row 2 · 2024-08-26 · Sale · Disposed 44,550 · Balance 120,664

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.19 to $15.01 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Row 3 · 2024-08-26 · Sale · Disposed 8,250 · Balance 112,414

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

Common StockSEC Table I · non-derivativeIndirectBy The Radoff Family Foundation15,046 Reported balance After 2024-08-26 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 4 · 2024-08-26 · Sale · Disposed 10,054 · Balance 15,046

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.39 to $14.38 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.05 to $13.85 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.19 to $15.01 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.39 to $14.38 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Rocky Mountain Chocolate Factory, Inc.

Report date October 23, 2024 · Filed October 25, 2024

Jointly reported with Radoff Bradley Louis

Section 16 reporting ended · disclosed 2024-10-25. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, $0.001 par value per shareSEC Table I · non-derivativeDirect450,148 Reported balance After 2024-10-23 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2024-10-23 · Sale · Disposed 12,400 · Balance 450,148

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that previously collectively beneficially owned more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Common Stock, $0.001 par value per shareSEC Table I · non-derivativeIndirectBy The Radoff Family Foundation299,817 Reported balance Holding disclosure · report date 2024-10-23 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 299,817

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that previously collectively beneficially owned more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that previously collectively beneficially owned more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 15, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 SaleCommon Stock 100 $1.06 $106.00
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 9

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 105,900

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
June 05, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 SaleCommon Stock 5,000 $1.15 $5,750.00
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 8

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 106,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
May 27, 2026 Filed May 30, 2026 00:30 UTC KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 SaleCommon Stock 24,059 $11.39 $274,094.56
Disclosure

SEC source: 0000921895-26-001507 · form409076051_05292026.xml · nonDerivative · entry 2

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 290,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F4 · price: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.9600 to $11.9600, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
May 27, 2026 Filed May 30, 2026 00:30 UTC KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 SaleCommon Stock 10,941 $10.78 $117,899.12
Disclosure

SEC source: 0000921895-26-001507 · form409076051_05292026.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 314,059

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · price: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.7600 to $10.9550, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
April 29, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseCommon Stock 1,009 $1.42 $1,436.92
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 7

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 111,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
April 27, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseCommon Stock 1,000 $1.40 $1,400.00
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 6

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 109,991

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
April 22, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseCommon Stock 500 $1.40 $700.00
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 5

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 108,991

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
April 22, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseCommon Stock 2,000 $1.43 $2,860.00
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 3

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,737

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
April 15, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseSeries D Preferred Stock · Derivative 1,000 $2.20 $2,200.90
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · derivative · entry 11

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,263

Underlying: Common Stock · 377 shares

Expires not disclosed

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · derivative.exercise_price: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

F3 · derivative.exercise_date: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

F3 · derivative.expiration_date: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

Read SEC document
April 14, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseSeries D Preferred Stock · Derivative 600 $2.13 $1,277.46
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · derivative · entry 10

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,263

Underlying: Common Stock · 226 shares

Expires not disclosed

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · derivative.exercise_price: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

F3 · derivative.exercise_date: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

F3 · derivative.expiration_date: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

Read SEC document
April 14, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseCommon Stock 3,511 $1.30 $4,553.42
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 2

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,737

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
April 13, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseCommon Stock 100 $1.21 $121.00
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 4

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 108,491

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

Read SEC document
April 13, 2026 Filed Aug 4, 2026 21:14 UTC REGIONAL HEALTH PROPERTIES, INC RHEP · Entity 8343 PurchaseCommon Stock 6,300 $1.29 $8,124.48
Disclosure

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,226

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
February 12, 2026 Filed Feb 12, 2026 22:56 UTC KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 PurchaseCommon Stock 30,000 $6.26 $187,944.00
Disclosure

SEC source: 0000921895-26-000312 · form409076051_02122026.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,180,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $6.1500 to $6.3700, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 14, 2025 Filed Nov 17, 2025 21:20 UTC KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 PurchaseCommon Stock 40,000 $5.78 $231,180.00
Disclosure

SEC source: 0000921895-25-003148 · form409076051_11172025.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,150,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $5.4400 to $5.9400, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 12, 2024 Filed Nov 13, 2024 16:13 UTC KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 PurchaseCommon Stock 32,501 $4.86 $157,980.86
Disclosure

SEC source: 0000921895-24-002606 · form409076051_11132024.xml · nonDerivative · entry 2

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,110,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $4.7800 to $4.9000, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 11, 2024 Filed Nov 13, 2024 16:13 UTC KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 PurchaseCommon Stock 17,499 $4.67 $81,734.33
Disclosure

SEC source: 0000921895-24-002606 · form409076051_11132024.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,077,499

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $4.5000 to $4.7000, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
October 23, 2024 Filed Oct 25, 2024 20:10 UTC Rocky Mountain Chocolate Factory, Inc. RMCF · Entity 1473 SaleCommon Stock, $0.001 par value per share 12,400 $2.70 $33,480.00
Disclosure

SEC source: 0000921895-24-002368 · form409076041_10252024.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 450,148

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that previously collectively beneficially owned more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
September 05, 2024 Filed Sep 6, 2024 14:17 UTC KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 PurchaseCommon Stock 29,912 $4.63 $138,570.33
Disclosure

SEC source: 0000921895-24-002104 · form409076051_09062024.xml · nonDerivative · entry 2

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 325,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $4.6000 to $4.6800, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Read SEC document
September 04, 2024 Filed Sep 6, 2024 14:17 UTC KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 PurchaseCommon Stock 30,088 $4.63 $139,226.20
Disclosure

SEC source: 0000921895-24-002104 · form409076051_09062024.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 295,088

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $4.5600 to $4.6900, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Read SEC document
August 26, 2024 Filed Aug 28, 2024 20:11 UTC Guardion Health Sciences, Inc. GHSI · Entity 87936 SaleCommon Stock 10,054 $13.80 $138,734.14
Disclosure

SEC source: 0000921895-24-001969 · form409076054_08282024.xml · nonDerivative · entry 4

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 15,046

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.39 to $14.38 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Read SEC document
August 26, 2024 Filed Aug 28, 2024 20:11 UTC Guardion Health Sciences, Inc. GHSI · Entity 87936 SaleCommon Stock 8,250 $15.77 $130,102.50
Disclosure

SEC source: 0000921895-24-001969 · form409076054_08282024.xml · nonDerivative · entry 3

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,414

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
August 26, 2024 Filed Aug 28, 2024 20:11 UTC Guardion Health Sciences, Inc. GHSI · Entity 87936 SaleCommon Stock 44,550 $14.46 $644,193.00
Disclosure

SEC source: 0000921895-24-001969 · form409076054_08282024.xml · nonDerivative · entry 2

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,664

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.19 to $15.01 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 26, 2024 Filed Aug 28, 2024 20:11 UTC Guardion Health Sciences, Inc. GHSI · Entity 87936 SaleCommon Stock 52,686 $13.54 $713,389.51
Disclosure

SEC source: 0000921895-24-001969 · form409076054_08282024.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,214

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.05 to $13.85 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 05, 2024 Filed Aug 5, 2024 21:15 UTC KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 PurchaseCommon Stock 50,500 $4.50 $227,143.95
Disclosure

SEC source: 0000921895-24-001685 · form409076051_08052024.xml · nonDerivative · entry 3

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,060,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F5 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $4.3900 to $4.6400, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
August 02, 2024 Filed Aug 5, 2024 21:15 UTC KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 PurchaseCommon Stock 63,159 $4.53 $286,350.27
Disclosure

SEC source: 0000921895-24-001685 · form409076051_08052024.xml · nonDerivative · entry 2

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 265,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $4.4700 to $4.5700, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 21:15 UTC KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 PurchaseCommon Stock 239,173 $4.35 $1,040,665.64
Disclosure

SEC source: 0000921895-24-001685 · form409076051_08052024.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,009,500

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $4.2935 to $4.6100, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
August 11, 2023 Filed Aug 15, 2023 20:15 UTC Lifevantage Corp LFVN · Entity 6941 PurchaseCommon Stock 20,000 $5.07 $101,332.00
Disclosure

SEC source: 0000921895-23-001976 · form409076057_08152023.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · See Footnote 1

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 50,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by the other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.

Read SEC document
January 10, 2023 Filed Jan 11, 2023 22:11 UTC Guardion Health Sciences, Inc. GHSI · Entity 87936 PurchaseCommon Stock 13,270 $8.00 $106,145.40
Disclosure

SEC source: 0000921895-23-000097 · form409076ghsi_01112023.xml · nonDerivative · entry 4

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,900

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.97 to $8.00 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

Read SEC document
January 10, 2023 Filed Jan 11, 2023 22:11 UTC Guardion Health Sciences, Inc. GHSI · Entity 87936 PurchaseCommon Stock 18,630 $7.31 $136,207.66
Disclosure

SEC source: 0000921895-23-000097 · form409076ghsi_01112023.xml · nonDerivative · entry 3

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,630

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.75 to $7.70 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

Read SEC document
January 09, 2023 Filed Jan 11, 2023 22:11 UTC Guardion Health Sciences, Inc. GHSI · Entity 87936 PurchaseCommon Stock 20,838 $7.19 $149,925.24
Disclosure

SEC source: 0000921895-23-000097 · form409076ghsi_01112023.xml · nonDerivative · entry 2

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.05 to $7.48 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

Read SEC document
January 09, 2023 Filed Jan 11, 2023 22:11 UTC Guardion Health Sciences, Inc. GHSI · Entity 87936 PurchaseCommon Stock 63,983 $6.78 $433,561.60
Disclosure

SEC source: 0000921895-23-000097 · form409076ghsi_01112023.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,162

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.7762 to $7.0417 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.

Read SEC document
October 05, 2022 Filed Oct 7, 2022 20:19 UTC FARMER BROTHERS CO FARM · Entity 49843 PurchaseCommon Stock 50,000 $5.05 $252,310.00
Disclosure

SEC source: 0000921895-22-002791 · form408569044_10072022.xml · nonDerivative · entry 2

Radoff Bradley Louis · CIK 0001380585 · See Footnote 1

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 125,000

F1 · security: The Reporting Persons may be deemed to be members of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that he or it is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Securities owned directly by the Radoff Foundation. As a director of the Radoff Foundation, Mr. Radoff may be deemed to beneficially own the securities owned directly by the Radoff Foundation.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.